The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of radium-223 in heavily pretreated metastatic castrate resistant prostate cancer (mCRPC) patients.
 
Dipenkumar Modi
No Relationships to Disclose
 
SeongHo Kim
No Relationships to Disclose
 
Hirva Mansurali Mamdani
No Relationships to Disclose
 
Clara Hwang
Stock and Other Ownership Interests - Johnson & Johnson (I); Pfizer (I)
Research Funding - Bayer; Dendreon; Exelixis
 
Hersham Gayar
Speakers' Bureau - Bayer
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis
 
Richard Joyrich
No Relationships to Disclose
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon
Research Funding - Agensys (Inst); Dendreon (Inst); Genentech/Roche (Inst); Millennium (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)